Athira Pharma To Participate In Upcoming June Conferences
Management to Highlight Robust Pipeline in Neurodegenerative Diseases with Key Phase 2/3 LIFT-AD Topline Data in Alzheimer's Disease on Track for Sec
Source: menafn.com
Key Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Key Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Key Phase Today - Breaking & Trending Today
Newcrest Mining Limited - Quarterly Report - 31 December 2022
For the three months ended 31 December 2022(figures are unaudited and in US$ except where stated)On track to deliver FY23 guidance as key growth projects advance to execution Solid second quarter with
Source: finanznachrichten.de
Newcrest Mining Limited: Newcrest Announces Lihir Phase 14A Feasibility Study Unlocks Value
Feasibility Study demonstrates attractive financial returns and a 2.9 year payback1,2,3 Incremental ~400koz of Phase 14A gold production expected over the next 4 years1,4,5 Study work underway to apply
Source: finanznachrichten.de
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that Varoglutamstat is Well Tolerated at Doses with High Target Inhibition, Highlighting Unique O
DGAP-News: Vivoryon Therapeutics N.V. / Key word: Study results/Study Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that... | July 31, 2022
Source: marketscreener.com
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showi
DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Study results/StudyVivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that Varoglutamstat is Well Tolerated at Doses with High Target Inhibition, Highlighting Unique O (news with additional features)31.07.2022 /...
Source: pharmiweb.com